Older Adults with Mild Cognitive Impairment Can Reliably Express Their Preferences for Health Care Using Discrete Choice Experiments

Published Jul 3, 2014
Adelaide, South Australia – Researchers from Flinders University found that mild cognitive impairment did not affect the ability of older adults to reliably respond to questions about their preferred rehabilitation services following hip fracture. Older adults (aged 65 years and over) represent an increasing proportion of the population with rising expectations for quality health and aged care services targeted to meet their needs and preferences. A recent study, “Cognitive Overload? An Exploration of the Potential Impact of Cognitive Functioning in Discrete Choice Experiments with Older People in Health Care,” published in Value in Health, was among the first to use discrete choice experiments (DCE), a popular method for quantifying preferences, to focus on older people, especially those with cognitive impairment. Through the use of a questionnaire completed by 74 older adults in the acute phase following a hip fracture to determine whether cognition influenced their ability to reliably complete a DCE, the researchers found that in comparison with those with good cognitive functioning, mild cognitive impairment did not influence the ability of older adults to respond reliably. Study co-author Professor Julie Ratcliffe, PhD, from Flinders University says, “This study demonstrates the ability of older adults, including those with mild cognitive impairment, to make reliable choices in relation to the characteristics of care of importance to them, and demonstrates the potential for the wider utilization of DCE methods to elicit treatment and service preferences across health and aged care sectors.”

Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research as well as policy papers to help health care leaders make evidence-based decisions. The journal is published bi-monthly and has over 8,000 subscribers (clinicians, decision makers, and researchers worldwide).

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health.

For more information: www.ispor.org

Related Stories

ISPOR Task Force Addresses Critical Gap in Surrogate Endpoint Guidance

May 28, 2026

Value in Health, announced the publication of an ISPOR Good Practices Report providing guidance on the use of surrogate endpoint evaluation methods in health technology assessment (HTA) decision making. The report, “Methods for Evaluation of Surrogate Endpoints for HTA Decision Making: A Good Practices Report of an ISPOR Task Force,” was published in the May 2026 issue of Value in Health.

How Is Health Valued in the United Kingdom? We Finally Have a Better Answer

May 27, 2026

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a pair of companion articles that together establish both the methodological foundation of the first definitive UK value set for the EQ-5D-5L and the practical implications of adopting it—thus equipping health technology assessment decision makers with a UK value set suitable for informing policy. The articles were featured in the May 2026 issue of Value in Health.

From Promise to Proof: Strengthening the Evidence Base for Digital Health Technologies

Apr 28, 2026

Value in Health announced the publication of a special themed section of research papers that advances evidence and methods for evaluating the real-world value of digital health technologies.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×